REGENERON PHARMACEUTICALS INC (REGN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for REGN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| REGN | Lead Independent Director | 73 | ["Former Executive-in-Residence in the Department of Management and Human Resources at The Ohio State University","Former Dean and John W. Berry, Sr. Chair in Business at The Ohio State University","Former Vice Chair and Worldwide Chair of Pharmaceuticals at Johnson & Johnson","Senior leadership positions at Bristol-Myers Squibb Company","Former member of the Supervisory Board of Royal Philips Electronics","Former board member at Decibel Therapeutics, Inc. and The Sherwin-Williams Company","Industry experience in pharmaceuticals","Business strategy and operations experience"] | ["Compensation Committee","Corporate Governance and Compliance Committee"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| NBIX | Director | 73 | ["Commercial Strategy/Market Access","Healthcare Industry","Biotech and Pharma Operations Expertise","M&A/Business Development Transactions","Governance","Investor Relations","Public Policy","Executive Leadership"] | ["Compensation","Science and Medical Technology"] | 2026 |
| PRU | Director | 73 | ["Executive in Residence at The Max M. Fisher College of Business at The Ohio State University", "Professor of Management and Human Resources at The Fisher College of Business", "Dean and John W. Berry, Sr. Chair in Business at The Fisher College of Business", "Vice Chair and Member of the Board of Directors of Johnson & Johnson", "Company Group Chair in the Pharmaceuticals Group at Johnson & Johnson", "Member of Johnson & Johnson\u2019s Executive Committee", "Worldwide Chair, Pharmaceuticals Group at Johnson & Johnson", "Worldwide Chair, Medicines and Nutritionals at Johnson & Johnson", "Various management positions at Bristol-Myers Squibb for 15 years"] | ["Executive", "Finance (Chair)", "Investment"] | 2026 |
| SHW | Retired, Former Vice Chairman, Johnson & Johnson; Director | 71 | ["Retired, Former Vice Chairman, Johnson & Johnson","Retired, Former Vice Chairman at Johnson & Johnson","Lead Independent Director of Regeneron Pharmaceuticals, Inc.","Director of Prudential Financial, Inc.","Director of Neurocrine Biosciences, Inc.","Former director of Decibel Therapeutics, Inc.","Former member and Vice-Chairwoman of the Supervisory Board of Koninklijke Philips N.V.","Over 20 years of experience at Johnson & Johnson and Bristol-Myers Squibb","Significant sales and marketing expertise in domestic and international markets"] | ["NCGC","Compensation Committee"] | 2024 |
| JNJ | Vice Chairman | 55 | ["Vice Chairman of the Board","Worldwide Chairman, Pharmaceuticals Group","Experience at Bristol-Myers Squibb Company"] | ["Executive Committee"] | 2008 |
Biography sourced from the proxy statement filing.
Age: 73 Director since: 2010 Lead Independent Director since: 2023 Board and Committee Membership 2025 Attendance Board of Directors: 14/15 Compensation Committee (Chair): 11/11 Corporate Governance and Compliance Committee: 5/5 Career Highlights Former Executive in Residence in the Department of Management and Human Resources (from 2015 to 2020) and former Dean and John W. Berry, Sr. Chair in Business (from 2009 to 2014) at The Max M. Fisher College of Business at The Ohio State University Former Vice Chair, Worldwide Chair of Pharmaceuticals, member of the Executive Committee, and member of the board of directors at Johnson & Johnson Previously held senior leadership positions at Bristol Myers Squibb Company, including President of International Medicines and President of Medical Devices Former member of the Supervisory Board of Royal Philips Electronics and the boards of directors of Decibel Therapeutics, Inc. and The Sherwin Williams Company Experience and Expertise Industry Experience Executive/Leadership Experience Science/Biotech Background Research/Academic Experience Business Strategy/ Operations Experience Financial Expertise Other Public Company Boards Neurocrine Biosciences, Inc. Prudential Financial, Inc. Reason for Nomination Ms. Poon s extensive expertise in domestic and international business operations, including sales and marketing and commercial operations, and her deep strategic and operational knowledge of the pharmaceutical industry, led to the board s decision to nominate Ms. Poon for reelection to the board.